Here’s what you should know.
1. LifeBond partnered with 20 medical centers to enroll patients into the study.
2. LifeBond will announce an additional 20 clinical sites soon.
3. Several Western European countries commercially use LifeSeal, which earned a CE Mark in April 2016.
4. The gastrointestinal-facing sealant provides reinforcement and minimize staple-line leakage.
More articles on gastroenterology:
GI leader to know: Dr. Ismail Wadiwala of Sutter Health
RedHill Biopharma’s Bekinda phase III study treats last patient: 4 things to know
Cantel Medical to acquire distributor’s endoscopy business assets: 3 key notes
